Swedish Orphan Biovitrum AB (publ) (BIOVF) Financials

BIOVF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 8.5 billion 4.3 billion
Dec. 31, 2025 7.3 billion 3.2 billion
Sept. 30, 2025 7.1 billion 3.3 billion
June 30, 2025 7.3 billion 3.1 billion

BIOVF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 91.1 million 7.5 million
Dec. 31, 2025 322.3 million 7.3 million
Sept. 30, 2025 193.2 million ?
June 30, 2025 108.6 million 6.0 million

BIOVF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 175.6 million
Dec. 31, 2025 201.7 million
Sept. 30, 2025 -305.2 million
June 30, 2025 84.0 million

BIOVF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 98.2 million 799.5 million 39.8 million
Dec. 31, 2025 112.8 million 589.2 million 28.1 million
Sept. 30, 2025 109.6 million 925.4 million 27.9 million
June 30, 2025 111.9 million 901.8 million 39.0 million

BIOVF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 36.5 million
Dec. 31, 2025 37.9 million
Sept. 30, 2025 36.6 million
June 30, 2025 36.7 million

BIOVF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 26.5 million 99.0 million 196.1 million -
Dec. 31, 2025 541676 95.2 million 321.9 million -
Sept. 30, 2025 849358 79.5 million -511.4 million -
June 30, 2025 44.5 million 90.0 million 213.6 million -

BIOVF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 750.4 million 182.5 million
Dec. 31, 2025 847.3 million 241.7 million
Sept. 30, 2025 819.8 million 953.2 million
June 30, 2025 653.2 million 150.8 million

BIOVF

Price: $48

52 week price:
27.06
48.00

Earnings Per Share: 0.28 USD

P/E Ratio: 169.11

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 16.4 billion

Links: